首页|脐带间充质干细胞(HUC-MSCs)质体(Cytoplast)来源CD64过表达纳米囊泡的构建方法研究

脐带间充质干细胞(HUC-MSCs)质体(Cytoplast)来源CD64过表达纳米囊泡的构建方法研究

扫码查看
目的:人脐带间充质干细胞(HUC-MSCs)来源的纳米颗粒可通过多种载药方式用于药物靶向,是近年来医药领域的研究热点。本文应用过表达CD64(FcγRI)的脐带间充质干细胞(HUC-MSCs)细胞质体(Cytoplast)为原料,制备可装载IgG1/IgG3靶向抗体的纳米囊泡,并检测纳米囊泡的入胞效率。方法:应用组织块培养法分离HUC-MSCs;建立pLV-CD64慢病毒包装载体并包装慢病毒,用慢病毒感染HUC-MSCs并筛选稳定表达CD64的细胞株;通过细胞松胞菌素B共孵育/离心法去除HUC-MSCs细胞核获得质体;超声法和梯度挤出法制备直径约200 nm的囊泡;将纳米囊泡与抗EGFR的IgG1抗体共孵育以装载靶向抗体,并观察该纳米囊泡进入A549细胞的入胞效率变化。结果:成功获得稳定表达CD64的HUC-MSCs质体,制备装载EGFR抗体的纳米囊泡(粒径为195±82nm)并有效提高了该囊泡对靶细胞的入胞效率。结论:成功构建可装载IgG1抗体的纳米微泡,该纳米囊泡可高效进入表达EGFR的A549靶细胞。
The Construction of CD64(FcγRI)Coated Nanovesicle From the Cytoplast of Human Umbilical Cord Mesenchymal Stem Cells(HUC-MSCs)
Objective:The nanovesicle derived from hum、an umbilical cord mesenchymal stem cells(HUC-MSCs)can be used for drug targeting through a variety of methods.The aim of this study is to construct the CD64(FcγRI)coated nanovesicle from the HUC-MSCs,and to detect the efficiency of antibodies(IgG1/IgG3)loading and cell entry of the nanovesicle.Methods:HUC-MSCs were isolated by tissue-cutting and cell culture method;A pLV-CD64 lentivirus packaging vector was established and packaged in the lentivirus;The lentivirus was transfected into HUC-MSCs,and the cell line that stably express CD64 was selected;The CD64 expressing HUC-MSCs was denuclearizated using the cytochalasin B co-incubation/centrifugation method;The nanovesicle with a diameter of ap-proximately 200 nm was generated by ultrasound and gradient extrusion methods.The nanovesicle was co-incubated with anti-EGFR IgG1 antibodies for antibody loading,and the entry efficiency of the nanovesicle was investigated in A549 cells.Results:The nanovesicle with the diameter of 195±82 nm,was obtained using the cytoplast of HUC-MSCs.The nanovesicle was stably expressing CD64 and successfully loaded with EGFR antibody;The modification effectively improved the entry efficiency of the nanovesicle for target cells.Conclusion:A nanovesicle with the capable of loading IgG1 antibodies was constructed,which could efficiently improve its entry effi-ciency for target cells.

Human umbilical cord mesenchymal stem cells(HUC-MSCs)CytoplastNanovesicleCD64(FcγRI)

张晓晓、张勇、徐溪、王高文、张艳、吕行、吴朔

展开 >

西京医院呼吸与危重症医学科 陕西西安 710032

脐带间充质干细胞(HUC-MSCs) 细胞质体(Cytoplast) 纳米囊泡 CD64(FcγRI)

国家自然科学基金青年基金

81902316

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(7)
  • 26